ClinicalTrialsFinder
RecruitingNCT06285500

Umbrella Study for Single Patient Treatments in Oncology

UNIQUE: Umbrella N-of-1 Tumor Trials - Umbrella Protocol for Oncology Single Patient Protocols

Sponsor

University Health Network, Toronto

Enrollment

400 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Advanced CancerRare Diseases

Summary

The purpose of this study is to collect data for assessing the improvement of the overall response rate for the overall cohorts and the proportion of patients accessing precision targeted therapy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Patient-specific treatments for people with advanced cancer and rare diseases. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient-specific treatments

Treatment will be decided specifically for the patient based on biomarker test results.

Locations(1)

University Health Network, Princess Margaret Cancer Centre

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06285500

Related Trials

Longitudinal Studies of Patient With FPDMM

NCT038543181 location

Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

NCT065959401 location

Personalized Neoantigen Peptide Vaccines for Solid Tumors

NCT070022031 location

SLV-154 Treatment of Advanced Cancers

NCT0677121910 locations

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

NCT0742675718 locations